OPHTHALMIC COMPOSITION COMPRISING CASTOR OIL AND A MEDIUM-CHAIN TRIGLYCERIDE
MA42197AUndetermined Publication Date: 2018-01-10LAB SALVAT SA
0 Cites 0 Cited by
Patent Information
- Application Number
- MA42197
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2016-07-07
- Publication Date
- 2018-01-10
Abstract
The present invention relates to a sterile ophthalmic composition comprising castor oil and a medium-chain triglyceride, intended for use in medicine, particularly for the treatment and / or prevention of an ocular disease selected from the group consisting of dry eye, conjunctivitis, dermatitis, blepharitis, entropion, dislocating eyelid syndrome, thyroid ophthalmopathy, pterygium, conjunctivochalosis, preservative-induced epithelial lesions, anterior chamber or epithelial lesions induced by ocular surgery, limbal cell deficiency, corneal ulcers induced by physical or chemical agents, keratitis, and uveitis.
Need to check novelty before this filing date? Find Prior Art